A pediatric perspective: Adult problems in kids, new challenges in pediatric diabetes

Pediatric Diabetes

Volumn 8, Issue 6, 2007, Pages 349-351

  Maahs, David M ^a   Daniels, Stephen R ^b  

^a CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD CARE; CHILD HEALTH; CHILDHOOD DISEASE; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC ERROR; DYSLIPIDEMIA; EDITORIAL; HEART DISEASE; HUMAN; JUVENILE DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; AGE FACTORS; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS, TYPE 2; HUMANS; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 36549010117     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00353.x     Document Type: Editorial

References (13)

1. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005: 146: 693-700.
2. Ogden CL, Carroll MD, Curtin LR, Mc Dowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006: 295: 1549-1555.
3. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002: 346: 393-403.
4. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001: 344: 1343-1350.
5. Standards of medical care in diabetes -2006. Diabetes Care 2006: 29 (Suppl. 1): S4-42.
6. Sellers EA, Yung G, Dean HJ. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes. Pediatr Diabetes 2007: 8: 384-390.
7. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 2006: 296: 421-426.
8. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. ISPAD clinical practice consensus guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes 2007: 8: 163-170.
9. Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care 2005: 28: 186-212.
10. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003: 26: 2194-2197.
11. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 2006: 114: 2710-2738.
12. Mc Crindle BW, Urbina EM, Dennison BA et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007: 115: 1948-1967.
13. Jolliffe CJ, Janssen I. Distribution of lipoproteins by age and gender in adolescents. Circulation 2006: 114: 1056-1062.